Editorial
doi: 10.1200/JCO.2002.20.15.3191.
Bisphosphonates and tumor burden
- PMID: 12149289
- DOI: 10.1200/JCO.2002.20.15.3191
Item in Clipboard
Editorial
Bisphosphonates and tumor burden
J Clin Oncol.
.
No abstract available
Comment on
-
Randomized, placebo-controlled trial of clodronate in patients with primary operable breast cancer.J Clin Oncol. 2002 Aug 1;20(15):3219-24. doi: 10.1200/JCO.2002.11.080. J Clin Oncol. 2002. PMID: 12149294 Clinical Trial.
Similar articles
-
Bisphosphonates as adjuvant treatment for breast cancer.BMJ. 2002 Nov 9;325(7372):1051-2. doi: 10.1136/bmj.325.7372.1051. BMJ. 2002. PMID: 12424151 Free PMC article. No abstract available.
-
Should oral bisphosphonates be standard of care in women with early breast cancer?Breast Cancer Res Treat. 2005 Apr;90(3):315-8. doi: 10.1007/s10549-004-4259-3. Breast Cancer Res Treat. 2005. PMID: 15830146 Review.
-
Randomized, placebo-controlled trial of clodronate in patients with primary operable breast cancer.J Clin Oncol. 2002 Aug 1;20(15):3219-24. doi: 10.1200/JCO.2002.11.080. J Clin Oncol. 2002. PMID: 12149294 Clinical Trial.
-
Bisphosphonates as anticancer drugs.N Engl J Med. 1998 Aug 6;339(6):398-400. doi: 10.1056/NEJM199808063390609. N Engl J Med. 1998. PMID: 9691109 No abstract available.
-
[Expanding the possibilities of using biphosphonates for prophylaxis and treatment of osteal complications in malignant metastasis].Eksp Klin Farmakol. 2004 Nov-Dec;67(6):66-71. Eksp Klin Farmakol. 2004. PMID: 15707020 Review. Russian.
Cited by
-
Platelet-Rich Plasma in Treatment of Zoledronic Acid-Induced Bisphosphonate-related Osteonecrosis of the Jaws.Trauma Mon. 2014 Apr;19(2):e17196. doi: 10.5812/traumamon.17196. Epub 2014 Mar 18. Trauma Mon. 2014. PMID: 25032151 Free PMC article.
-
Zoledronic acid and clodronate in the treatment of malignant bone metastases with hypercalcaemia; efficacy and safety comparative study.Med Oncol. 2011 Jun;28(2):584-90. doi: 10.1007/s12032-010-9461-z. Epub 2010 Mar 5. Med Oncol. 2011. PMID: 20204542 Clinical Trial.
-
All bone metastases are not created equal: Revisiting treatment resistance in renal cell carcinoma.J Bone Oncol. 2021 Oct 20;31:100399. doi: 10.1016/j.jbo.2021.100399. eCollection 2021 Dec. J Bone Oncol. 2021. PMID: 34745857 Free PMC article. Review.
-
Should all adjuvant breast cancer patients receive a bisphosphonate?Breast Cancer Res. 2003;5(6):296-9. doi: 10.1186/bcr648. Epub 2003 Oct 1. Breast Cancer Res. 2003. PMID: 14580244 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
